P04.9

Clinical Causes: Maternal use of illicit drugs during pregnancy (e.g., cocaine, methamphetamine, heroin). Consumption of alcohol by the mother during pregnancy, leading to fetal alcohol spectrum disorders. Exposure to certain medications that are teratogenic or have harmful effects on the developing fetus. Use of toxic substances such as environmental pollutants or chemicals by the mother during pregnancy. Maternal smoking, which exposes the fetus to harmful chemicals that may cause developmental issues.

Key Symptoms: Low birth weight and small size for gestational age. Withdrawal symptoms such as tremors, irritability, feeding difficulties, and abnormal sleeping patterns. Problems with breathing, including respiratory distress or apneas. Congenital anomalies or structural abnormalities. Developmental delays or neurological impairments. Lethargy or excessive sleepiness. Feeding problems, including difficulty suckling or swallowing. Unusual crying or high-pitched vocalizations.

Diagnosis Path: Diagnosis typically involves a combination of prenatal history, physical examinations, and screening tests. Healthcare providers might review maternal substance use history and look for signs of withdrawal or injury. Laboratory tests, such as blood or urine screens, can confirm exposure to specific substances. Imaging studies or neurological assessments may be used if structural anomalies or neurological impairments are suspected. Overall, diagnosis aims to identify the impact of maternal substances on the newborn's health to guide proper management.

Treatment Protocols: Monitoring of vital signs and newborn behavior. Management of withdrawal symptoms with medications if necessary, under medical supervision. Nutritional support to address feeding difficulties. Ensuring a safe and supportive environment to promote development. Medical treatments for any congenital abnormalities or complications identified. Referral to specialists such as neurologists or developmental therapists for ongoing care. Supporting the mother in substance cessation and providing counseling or social services to reduce the risk of future complications.